cannabis indica

Náusea e Vômito

termo de indexação original: Nausea and Vomiting

O acervo do Cannabis Indica reúne 262 estudos científicos que tocam a condição Náusea e Vômito, publicados entre 1975 e 2024. Pela leitura automatizada, 159 (61%) foram classificados como favoráveis, 40 (15%) como inconclusivos e 63 (24%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (169 estudos), seguido de ensaio clínico duplo-cego (35). Os compostos mais presentes são THC Farmacêutico, Tetraidrocanabinol (THC) e Anandamida (AEA). Aparece com frequência ao lado de Dor, Náusea e Vômito por Quimioterapia e Câncer.

Estudos indexados
262
Período coberto
1975–2024
Favoráveis
159 · 61%
Inconclusivos
40 · 15%
Desfavoráveis
63 · 24%
Termo original
Nausea and Vomiting

O acervo em números

Tipo de estudo

Metanálise169
Ensaio Clínico Duplo-Cego35
Ensaio Clínico26
Estudo em Animais20
Metanálise Clínica9
Estudo Laboratorial3

Direção do resultado

Favorável159
Inconclusivo40
Desfavorável63

Por década

1970s3
1980s20
1990s4
2000s23
2010s78
2020s134

262 estudos

Filtrar e buscar no acervo →
  1. 2024

    Acute and Long-Term Effects of App-Delivered Heartfulness Meditation on Psychological Outcomes and the Endocannabinoid Signaling System in Cyclic Vomiting Syndrome

  2. 2024

    AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary

  3. 2024

    Cannabis induced gastrointestinal tract symptoms in the adult population: a systematic review

  4. 2024

    Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium

  5. 2024

    Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study

  6. 2023

    A Case of a Patient With Cannabis Hyperemesis Syndrome Along With Recurrent Nephrolithiasis

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+7
  7. 2023

    A Case of Cannabinoid Hyperemesis Syndrome and Acute Kidney Injury: A Review of the Literature

  8. 2023

    A case of panic attack developing after THC-O acetate inhalation using an e-cigarette device

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+4
  9. 2023

    A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History

    DesfavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)Canabigerol (CBG)+13
  10. 2023

    A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy

  11. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+25
  12. 2023

    Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus

  13. 2023

    Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

    InconclusivoMetanálise ClínicaDorDependência QuímicaCâncer+15
  14. 2023

    Cannabis-Induced ST-Segment Elevation Myocardial Infarction With Possible Coronary Artery Dissection: A Case Report

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+7
  15. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  16. 2023

    Late Onset Diaphragmatic Hernia: A Forgotten Etiology of Recurrent Vomiting in the Adolescent Population

    DesfavorávelMetanáliseDorDiabetesSíndrome da Hiperêmese Canabinoide
  17. 2023

    Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest

  18. 2023

    Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

    FavorávelMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+16
  19. 2023

    Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial

    FavorávelEnsaio Clínico Duplo-CegoCâncerNáusea e Vômito por QuimioterapiaCâncer — Ovário+2
  20. 2023

    Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection

    InconclusivoMetanálise ClínicaDorCâncerAnsiedadeTHC FarmacêuticoTHC:CBD Farmacêutico+9
  21. 2023

    Recurrent Severe Burns Due to Cannabinoid Hyperemesis Syndrome

  22. 2023

    Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder

  23. 2023

    The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study

    FavorávelMetanáliseAnsiedadeDepressãoTEPT+1
  24. 2023

    The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicoseGestação
  25. 2022

    A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

  26. 2022

    A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong

  27. 2022

    A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment

    FavorávelMetanáliseDorCâncerAnsiedade+5
  28. 2022

    A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment

    FavorávelMetanáliseDorCâncerAnsiedadeAnandamida (AEA)Tetraidrocanabinol (THC)+25
  29. 2022

    Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services

  30. 2022

    Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020

  31. 2022

    Biophysical Studies and In Vitro Effects of Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes

    FavorávelEstudo LaboratorialDorCâncerDor — OncológicaTetraidrocanabinol (THC)+3
  32. 2022

    Cannabidiol for Functional Dyspepsia With Normal Gastric Emptying: A Randomized Controlled Trial

  33. 2022

    Cannabidiol in canine epilepsy

    InconclusivoMetanáliseDorCâncerInflamaçãoÁcido Canabidiólico (CBD-a)+7
  34. 2022

    Cannabidiol Interferes with Establishment of Δ 9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism

  35. 2022

    Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department

  36. 2022

    Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review

    DesfavorávelMetanáliseDorInflamaçãoAnsiedade+10
  37. 2022

    Cannabinoids in rheumatology: Friend, foe or a bystander?

  38. 2022

    Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

  39. 2022

    Cannabis in Palliative Care: A Systematic Review of Current Evidence

    InconclusivoMetanáliseCâncerEpilepsiaInsônia e Distúrbios do Sono+6
  40. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  41. 2022

    Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care

    FavorávelMetanáliseDorCâncerDor — Oncológica
  42. 2022

    Case report: A case of undiagnosed cannabinoid hyperemesis syndrome in rural part of Nepal

  43. 2022

    Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+7
  44. 2022

    Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol

    DesfavorávelEnsaio ClínicoDependência QuímicaEfeitos Adversos da CannabisPsicose+2
  45. 2022

    Comparative light and scanning electron microscopic studies of pollen of two marijuana species causing allergies

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisAlergia à Cannabis
  46. 2022

    Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

  47. 2022

    Effectiveness of Nutritional Ingredients on Upper Gastrointestinal Conditions and Symptoms: A Narrative Review

    FavorávelMetanáliseRefluxo Gastroesofágico
  48. 2022

    Evaluation of Sex Differences in the Potential of Δ9-Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats

  49. 2022

    Herbal Approaches to Pediatric Functional Abdominal Pain

    InconclusivoMetanáliseDorInflamaçãoDor — CrônicaTHC Farmacêutico+10
  50. 2022

    Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTHC:CBD Farmacêutico+14
  51. 2022

    In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center

    FavorávelMetanáliseDorCâncerAnsiedade+14
  52. 2022

    Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies

  53. 2022

    Malignant Syphilis in a Female Patient: A Case Report and Mini-Review

    DesfavorávelMetanáliseCâncerInflamaçãoEfeitos Adversos da Cannabis+11
  54. 2022

    Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence

    FavorávelMetanáliseDorEfeitos Adversos da CannabisEnxaquecaTHC Farmacêutico
  55. 2022

    Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer

  56. 2022

    Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum

  57. 2022

    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

  58. 2022

    Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature

  59. 2022

    Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

  60. 2022

    Pneumomediastinum and Pneumorrhachis Associated With Cannabinoid Hyperemesis Syndrome

  61. 2022

    Pneumopericardium, Epidural Pneumatosis, and Muscular Emphysema: Rare Complications of Spontaneous Pneumomediastinum Due to Refractory Hyperemesis Gravidarum

  62. 2022

    Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  63. 2022

    Pregnant People's Perspectives On Cannabis Use During Pregnancy: A Systematic Review and Integrative Mixed-Methods Research Synthesis

    FavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+7
  64. 2022

    Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada

    FavorávelMetanáliseDorDor — CrônicaDepressão+5
  65. 2022

    Role of cannabis in inflammatory bowel diseases

  66. 2022

    Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review

    FavorávelMetanáliseDorCâncerDor — Crônica+1
  67. 2022

    Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Ayahuasca Use in a Satanic Ritual: A Case Report

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)EpilepsiaPsicoseAyahuasca+6
  68. 2022

    Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?

  69. 2022

    The Effectiveness of Common Cannabis Products for Treatment of Nausea

  70. 2022

    The effects of collagen peptides on exercise-induced gastrointestinal stress: a randomized, controlled trial

  71. 2022

    The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials

    FavorávelMetanálise ClínicaDorCâncerEfeitos Adversos da CannabisTHC Farmacêutico+7
  72. 2022

    Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation

  73. 2022

    Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals

  74. 2022

    TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

  75. 2022

    Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome

  76. 2021

    A 23-year-old man with acute lung injury after using a tetrahydrocannabinol-containing vaping device: a case report

  77. 2021

    A 41-Year-Old Man Presenting With Shortness of Breath, Nausea, Vomiting, and Diarrhea

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeEnxaqueca+2
  78. 2021

    A Reason to Rethink Fasting Guidelines? Marijuana-Induced Gastroparesis and the Implications for Aspiration Risk in the Nil Per Os (NPO) Patient: A Case Report

  79. 2021

    A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options

  80. 2021

    A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies?

    DesfavorávelMetanáliseDorPerda de ApetiteDiarreia
  81. 2021

    Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol

    FavorávelMetanáliseDorDependência QuímicaInflamação+7
  82. 2021

    Adverse Effects of Recreational and Medical Cannabis

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+2
  83. 2021

    Are Canadian Cannabis Dispensaries Counselling Pregnant Women Appropriately?

    InconclusivoMetanáliseGestação
  84. 2021

    Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+5
  85. 2021

    Cannabinoid hyperemesis syndrome can be relieved by warm baths

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDependência — Cannabis+2
  86. 2021

    Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use

  87. 2021

    Cannabinoid Hyperemesis Syndrome: A Case Study in a Tunisian Young Man

  88. 2021

    Cannabis consumption in young adults with cancer: descriptive study

    FavorávelMetanáliseDorCâncerAnsiedade+3
  89. 2021

    Cannabis Use among Cancer Survivors amid the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study

    InconclusivoEnsaio ClínicoCâncerEpilepsiaInsônia e Distúrbios do Sono+3
  90. 2021

    Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome

    FavorávelEstudo em AnimaisDorAnsiedadeDor — CrônicaÁcido Canabidiólico (CBD-a)+4
  91. 2021

    Death of a young woman with cyclic vomiting: a case report

  92. 2021

    Desistance, Self-treatment, or Substitution: Decisions about Cannabis Use During Pregnancy

    InconclusivoMetanáliseEfeitos Adversos da CannabisDependência — CannabisAnsiedade+3
  93. 2021

    Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department

  94. 2021

    Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management

    FavorávelMetanáliseDorCâncerAnsiedade+4
  95. 2021

    Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients

    FavorávelMetanáliseDorCâncerInsônia e Distúrbios do Sono+1
  96. 2021

    Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research

    FavorávelMetanáliseDorDependência QuímicaCâncer+16
  97. 2021

    Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaEfeitos Adversos da Cannabis+2
  98. 2021

    Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey

    FavorávelMetanáliseDorCâncerInsônia e Distúrbios do Sono+2
  99. 2021

    Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

  100. 2021

    Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?

    InconclusivoMetanáliseDorCâncerAnsiedade+5
  101. 2021

    Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?

    FavorávelMetanáliseDorCâncerDor — Crônica+5
  102. 2021

    Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida

    FavorávelMetanáliseDorDor — CrônicaDepressão+6
  103. 2021

    Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review

    InconclusivoMetanáliseDorAnsiedadeDor — Crônica+3
  104. 2021

    Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies

    InconclusivoMetanáliseDorDor — CrônicaDependência — Opioides+3
  105. 2021

    Perinatal Cannabis Exposures and Autism Spectrum Disorders

  106. 2021

    Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process

    InconclusivoMetanáliseDorDor — Aguda
  107. 2021

    Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer

    FavorávelMetanáliseDorCâncerDor — Crônica+7
  108. 2021

    Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases

  109. 2021

    Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

  110. 2021

    The Use of Cannabis and Cannabinoid-based Products by Pregnant Women: A Patent Review

    FavorávelMetanáliseDorInflamaçãoDor — Aguda+1
  111. 2021

    Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting

  112. 2021

    Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland

  113. 2021

    Vape-Associated Pulmonary Injury (VAPI) Presenting With a "Miliary" Pattern on Imaging

    DesfavorávelMetanáliseInflamaçãoEfeitos Adversos da CannabisPerda de Apetite+3
  114. 2020

    19-Year-Old Man With Fevers, Abdominal Pain, and Cough

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Aguda+2
  115. 2020

    A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework

    FavorávelMetanáliseDorDor — Aguda
  116. 2020

    A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoAnsiedadeEpilepsia
  117. 2020

    A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome

    FavorávelEnsaio Clínico Duplo-CegoDorDor — AgudaSíndrome da Hiperêmese CanabinoideCapsaicina (CAPS)+1
  118. 2020

    Brodifacoum-Laced Synthetic Marijuana Toxicity: A Fight Against Time

  119. 2020

    Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice

    FavorávelEstudo em AnimaisDorAnsiedadeEpilepsiaÁcido Canabidiólico (CBD-a)
  120. 2020

    Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDepressão+9
  121. 2020

    Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition

  122. 2020

    Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeDor — AgudaTHC Farmacêutico+1
  123. 2020

    Cannabinoids use in adolescents and young adults with cancer: a single-center survey

    FavorávelMetanáliseDorCâncerAnsiedade+1
  124. 2020

    Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study

  125. 2020

    Do Not Huff, Puff, or Vape That Stuff: Interstitial Airspace Disease in a Teenager

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+6
  126. 2020

    Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

  127. 2020

    Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews

  128. 2020

    Medicinal Use of Cannabis in Children and Pregnant Women

  129. 2020

    Myocardial ischaemia associated with tetrahydrocannabinol intake in a teenage boy: A case report

  130. 2020

    Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

    FavorávelEnsaio Clínico Duplo-CegoCâncerNáusea e Vômito por QuimioterapiaTHC:CBD Farmacêutico
  131. 2020

    Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy

  132. 2020

    Sleep and neurochemical modulation by cannabidiolic acid methyl ester in rats

  133. 2020

    Small bowel intussusception in marijuana users

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+6
  134. 2020

    The use of cannabis for Hyperemesis Gravidarum (HG)

    FavorávelMetanáliseGestaçãoEnjoo Matinal na Gestação
  135. 2019

    Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States

    DesfavorávelMetanáliseDependência — CannabisSíndrome da Hiperêmese Canabinoide
  136. 2019

    Cannabidiol Adverse Effects and Toxicity

    DesfavorávelMetanáliseEfeitos Adversos da CannabisInsônia e Distúrbios do Sono
  137. 2019

    Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting

    FavorávelMetanáliseNáusea e Vômito por Quimioterapia
  138. 2019

    Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology

    FavorávelMetanáliseDorAnsiedadeAnorexia (perda de apetite)+1
  139. 2019

    Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota's Medical Cannabis Program

    FavorávelMetanáliseDorCâncer
  140. 2019

    Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis

    FavorávelMetanáliseDorCâncerEsclerose Múltipla+7
  141. 2019

    Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum

  142. 2019

    Priority Considerations for Medicinal Cannabis-Related Research

    FavorávelMetanáliseDorCâncerAnsiedade+16
  143. 2019

    Recent trends in cyclic vomiting syndrome-associated hospitalisations with liberalisation of cannabis use in the state of Colorado

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  144. 2019

    Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome

  145. 2019

    Severe hyponatremia secondary to Phyllomedusa bicolor (Kambó frog) poisoning. Report of one case

    InconclusivoMetanáliseAyahuasca
  146. 2019

    US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+16
  147. 2019

    Use of Cannabis in Gastroenterological and Hepatic Disorders

  148. 2018

    Cannabidiol for drug-resistant seizures in the Dravet syndrome

  149. 2018

    Cannabinoid pharmacology and therapy in gut disorders

    FavorávelMetanáliseCâncerSíndrome do Intestino IrritávelCâncer — Cólon
  150. 2018

    Cannabis Use, Lung Cancer, and Related Issues

    FavorávelMetanáliseDorCâncerAnsiedadeTHC Farmacêutico+3
  151. 2018

    Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer

  152. 2018

    Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model

    FavorávelEstudo em AnimaisCâncerInflamaçãoEstresse Oxidativo+8
  153. 2018

    Medical use of cannabis: Italian and European legislation.

  154. 2018

    Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain

    FavorávelMetanáliseDorDor — CrônicaDor — Oncológica+1
  155. 2018

    Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

    FavorávelEnsaio Clínico Duplo-CegoEpilepsiaEpilepsia — Síndrome de DravetPerda de Apetite
  156. 2018

    Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDepressãoDependência — ÁlcoolDiarreiaAyahuasca+1
  157. 2018

    Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review

    DesfavorávelMetanáliseCâncerNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  158. 2018

    Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.

    FavorávelMetanáliseDorDor — CrônicaEsclerose Múltipla+2
  159. 2018

    The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+7
  160. 2017

    A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery

  161. 2017

    Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

  162. 2017

    Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  163. 2017

    Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study

    FavorávelMetanáliseCâncerDor — Oncológica
  164. 2017

    Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  165. 2017

    Medical Cannabinoids in Children and Adolescents: A Systematic Review.

    FavorávelMetanáliseDorEpilepsiaDor — Neuropatia Periférica+2
  166. 2017

    Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

    FavorávelEnsaio Clínico Duplo-CegoEpilepsiaEpilepsia — Síndrome de DravetDiarreiaCBD Farmacêutico
  167. 2016

    Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

    FavorávelMetanáliseNáusea e Vômito por Quimioterapia
  168. 2016

    Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting.

  169. 2016

    Cannabinoids for Symptom Management and Cancer Therapy: The Evidence.

  170. 2016

    Cannabinoids in Palliative Care: Systematic Review and Meta-Analysis of Efficacy, Tolerability and Safety

    InconclusivoMetanálise ClínicaDorCâncerInsônia e Distúrbios do Sono+4
  171. 2016

    Cannabis - the Israeli perspective

  172. 2016

    Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

  173. 2016

    Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.

  174. 2016

    Endocannabinoid System: A Multi-Facet Therapeutic Target.

  175. 2016

    Endocannabinoids in the gastrointestinal tract

  176. 2016

    Integrating cannabis into clinical cancer care

    FavorávelMetanáliseDorCâncerAnorexia (perda de apetite)THC:CBD Farmacêutico+10
  177. 2015

    13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  178. 2015

    Cannabinoid hyperemesis syndrome: about 6 cases

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  179. 2015

    Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.

    FavorávelMetanáliseNáusea e Vômito por Quimioterapia
  180. 2015

    Endocannabinoid Mechanisms Influencing Nausea.

  181. 2015

    Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorCâncerInsônia e Distúrbios do SonoTHC Farmacêutico+5
  182. 2015

    Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  183. 2015

    Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.

    FavorávelMetanáliseNáusea e Vômito por Quimioterapia
  184. 2015

    Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects

    DesfavorávelEnsaio ClínicoAnandamida (AEA)Endocanabinoide (não especificado)+1
  185. 2015

    Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.

    FavorávelMetanáliseDorCâncerDoenças Cardiovasculares (DCV)+9
  186. 2014

    Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system

    FavorávelEstudo em AnimaisCinetoseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  187. 2014

    Marijuana Use and Maternal Experiences of Severe Nausea During Pregnancy in Hawai‘i

    DesfavorávelMetanáliseGestaçãoEnjoo Matinal na Gestação
  188. 2014

    Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting

    FavorávelMetanáliseSíndrome da Hiperêmese CanabinoideTHC Farmacêutico
  189. 2013

    A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids

  190. 2013

    A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain

    FavorávelEnsaio ClínicoDorCâncerAnsiedadeTHC:CBD Farmacêutico+5
  191. 2013

    Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

  192. 2013

    Cannabinoid Hyperemesis Syndrome

  193. 2013

    Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis

    FavorávelMetanáliseCâncerCâncer — ÚteroTHC Farmacêutico
  194. 2013

    Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs

    FavorávelEstudo em AnimaisDorCâncerPsicoseTHC Farmacêutico+10
  195. 2013

    Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats

    FavorávelEstudo em AnimaisTetraidrocanabivarina (THCV)Canabidivarina (CBDV)
  196. 2013

    Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

  197. 2012

    An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics

  198. 2012

    Antidepressant activity of Litsea glaucescens essential oil: Identification of β-pinene and linalool as active principles

    FavorávelEstudo LaboratorialDorAnsiedadeDepressãoMedicina Mente-Corpo+6
  199. 2012

    Association of Marijuana Use and Cyclic Vomiting Syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  200. 2012

    Cannabinoid hyperemesis syndrome: a case series and review of previous reports

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  201. 2012

    Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.

    FavorávelMetanáliseTHC Farmacêutico
  202. 2012

    Cannabis—A Valuable Drug That Deserves Better Treatment

  203. 2012

    Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerEsclerose MúltiplaTHC Farmacêutico+3
  204. 2012

    Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.

  205. 2011

    A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)

  206. 2011

    Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.

    FavorávelMetanáliseNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  207. 2011

    Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerInflamaçãoTHC Farmacêutico+9
  208. 2011

    Efficacy and safety of CP-945,598, a selective cannabinoid CB1 receptor antagonist, on weight loss and maintenance

    FavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeObesidadeCanabinoides Sintéticos CP-x+4
  209. 2011

    Update and new trends in antiemetic therapy: the continuing need for novel therapies.

    FavorávelMetanáliseNáusea e Vômito por Quimioterapia
  210. 2010

    Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood

    FavorávelMetanálise ClínicaNáusea e Vômito por Quimioterapia
  211. 2010

    Motion Sickness, Stress And The Endocannabinoid System.

    FavorávelEnsaio ClínicoCinetoseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  212. 2010

    Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTHC:CBD Farmacêutico
  213. 2009

    Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review.

    FavorávelMetanáliseNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  214. 2009

    Marijuana Effectiveness As An HIV Self-care Strategy

    FavorávelMetanáliseAnsiedadeDepressãoHIV/AIDS
  215. 2008

    Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.

    FavorávelMetanáliseAnorexia (perda de apetite)Hepatite
  216. 2008

    Targeting the endocannabinoid system: to enhance or reduce?

  217. 2008

    The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis in Suncus murinus.

    FavorávelEstudo em AnimaisCinetoseTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x
  218. 2007

    Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret

  219. 2007

    Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  220. 2007

    Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew

  221. 2007

    Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.

    FavorávelEnsaio ClínicoAnorexia (perda de apetite)HIV/AIDSCaquexiaTHC Farmacêutico
  222. 2006

    Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases

  223. 2006

    Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'.

    FavorávelMetanáliseEnjoo Matinal na Gestação
  224. 2006

    The emerging role of cannabinoid neuromodulators in symptom management.

    FavorávelMetanálise ClínicaDorCâncerDor — OncológicaTHC Farmacêutico+1
  225. 2005

    Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomiting

    FavorávelEstudo em AnimaisCâncer
  226. 2005

    Survey of Australians using cannabis for medical purposes

    FavorávelMetanáliseDorDor — CrônicaDepressão+3
  227. 2004

    Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  228. 2003

    Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

    FavorávelMetanáliseÁcido Canabidiólico (CBD-a)
  229. 2003

    Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

  230. 2003

    Established and potential therapeutic applications of cannabinoids in oncology.

    FavorávelMetanáliseAnorexia (perda de apetite)THC Farmacêutico
  231. 2002

    Cannabidiol: an overview of some pharmacological aspects

    FavorávelMetanáliseAnsiedadeEpilepsiaPsicoseAnandamida (AEA)+4
  232. 2002

    Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

    InconclusivoEnsaio ClínicoTHC Farmacêutico
  233. 2001

    Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac

    InconclusivoEnsaio Clínico
  234. 2001

    Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.

  235. 2001

    Hu 210: a potent tool for investigations of the cannabinoid system

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaCanabinoides Sintéticos HU-x+3
  236. 1997

    Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).

    FavorávelMetanáliseDorCâncerDor — OncológicaTHC Farmacêutico+8
  237. 1995

    An efficient new cannabinoid antiemetic in pediatric oncology.

    FavorávelEnsaio ClínicoNáusea e Vômito por QuimioterapiaDelta-8-THC
  238. 1991

    Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTetraidrocanabinol (THC)THC Farmacêutico
  239. 1990

    Case report: the effect of tetrahydrocannabinol on food intake during chemotherapy

  240. 1989

    Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid

  241. 1989

    Nabilone as effective therapy for intractable nausea and vomiting in AIDS

    FavorávelMetanáliseHIV/AIDSTHC Farmacêutico
  242. 1988

    A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues

  243. 1988

    Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy

    FavorávelEnsaio ClínicoNáusea e Vômito por Quimioterapia
  244. 1988

    Inhalation marijuana as an antiemetic for cancer chemotherapy

    FavorávelEnsaio ClínicoNáusea e Vômito por Quimioterapia
  245. 1987

    A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea.

    InconclusivoEnsaio Clínico Duplo-CegoSíndrome Aguda da Radiação
  246. 1987

    Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por Quimioterapia
  247. 1986

    Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por Quimioterapia
  248. 1986

    Nabilone: an alternative antiemetic for cancer chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  249. 1986

    Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis

  250. 1985

    A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  251. 1985

    Antiemetic Efficacy of Levonantradol Compared to delta-9-tetrahydrocannabinol for Chemotherapy-Induced Nausea and Vomiting

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaCanabinoides Sintéticos CP-x
  252. 1985

    Phase 1 Trial of Levonantradol in Chemotherapy-Induced Emesis

    FavorávelEnsaio ClínicoNáusea e Vômito por QuimioterapiaCanabinoides Sintéticos CP-x
  253. 1983

    A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  254. 1983

    A randomised multicentre single blind comparison of a cannabinoid anti-emetic (Levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaCanabinoides Sintéticos CP-x
  255. 1983

    Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por Quimioterapia
  256. 1983

    Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  257. 1982

    A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTetraidrocanabinol (THC)THC Farmacêutico
  258. 1982

    Cannabis and cancer chemotherapy. A comparison of oral delta-9-THC and prochlorperazine

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por Quimioterapia
  259. 1981

    Antiemetic Effect of Δ9‐Tetrahydrocannabinol in Chemotherapy‐Associated Nausea and Emesis As Compared to Placebo and Compazine.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTetraidrocanabinol (THC)
  260. 1979

    Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por QuimioterapiaTetraidrocanabinol (THC)
  261. 1978

    Toward drugs derived from Cannabis

  262. 1975

    Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito por Quimioterapia

Continue por aqui

Perguntas frequentes

Quantos estudos sobre náusea e vômito estão indexados no acervo?
São 262 estudos, publicados entre 1975 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 169 · Ensaio Clínico Duplo-Cego: 35 · Ensaio Clínico: 26 · Estudo em Animais: 20 · Metanálise Clínica: 9 · Estudo Laboratorial: 3. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 159 favoráveis, 40 inconclusivos e 63 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Náusea e Vômito — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/nausea-e-vomito/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Náusea e Vômito — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/nausea-e-vomito/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.